Association of vancomycin plus piperacillin–tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study
Todd A. Miano(University of Pennsylvania), M.G.S. Shashaty(University of Pennsylvania), C.A.G. Ittner(University of Pennsylvania), Ariel R. Weisman(University of Pennsylvania), R.S. Agyekum(Translational Therapeutics (United States)), Nuala J. Meyer(Translational Therapeutics (United States)), Raymond R. Townsend(University of Pennsylvania), Brian J. Anderson(University of Pennsylvania), Tiffanie K. Jones(University of Pennsylvania), H.M. Giannini(Lung Institute), Christopher V. Cosgriff(University of Pennsylvania), Wei Yang(Kidney Research UK), John P. Reilly(University of Pennsylvania), Alexandra P. Turner(University of Pennsylvania), Oluwatosin Oniyide(University of Pennsylvania), F. Perry Wilson(Yale University), Thomas Dunn(Translational Therapeutics (United States)), Sean Hennessy(Translational Therapeutics (United States))
Cited by 98
Related Papers
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness
|Hypertension|2015|1.4k
Clinical Practice Guidelines for the Management of Hypertension in the Community
|Journal of Clinical Hypertension|2013|1k